Skip to main content



) --

Watson Pharmaceuticals



) hit a new 52-week high Thursday as it is currently trading at $63.86, above its previous 52-week high of $63.85 with 1.3 million shares traded as of 2:37 p.m. ET. Average volume has been 1.1 million shares over the past 30 days.

Watson has a market cap of $7.8 billion and is part of the

health care

sector and



Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacturing, marketing, sale, and distribution of brand and off-patent (generic) pharmaceutical products in the United States and internationally.

  • Practice your WPI trading strategies and win cash in our stock game.

TheStreet Ratings rates Watson as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full

Watson Ratings Report


See all

52-week high stocks

or get investment ideas from our

investment research center